Abstract
The β-blocker (S)-betaxolol has been synthesized in 99% enantiomeric excess (ee) from the commercially available precursor 4-(2-hydroxyethyl)phenol. The racemic chlorohydrin 1-chloro-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol was esterified with vinyl acetate catalyzed by lipase B from Candida antarctica, which gave the R-chlorhydrin (R)-1-chloro-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol in 99% ee with 38% yield. The enantiomeric excess of the R-chlorohydrin was retained in an amination reaction with isopropylamine in methanol to yield (S)-betaxolol in 99% ee and with 9% overall yield. We are under way to improve the yield.
Subject
Physical and Theoretical Chemistry,Catalysis,General Environmental Science
Reference24 articles.
1. Al-Majed, A. (2021). Chapter Three-Betaxolol: A Comprehensive Profile in Profiles of Drug Substances, Excipients and Related Methodology, Academic Press.
2. Primary open-angle glaucoma;Weinreb;Lancet,2004
3. The number of people with glaucoma worldwide in 2010 and 2020;Quigley;Br. J. Ophthalmol.,2006
4. Single enantiomeric b-blockers. The existing technologies;Agustian;Process Biochem.,2010
5. (1992). FDA’s policy statement for the development of new stereoisomeric drugs. Chirality, 4, 338–340.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献